Developing policy positions for orphan medicine products

Stethoscope on books

Our client was looking to update its global policy position statements to be utilized across the globe by staff members and serving as basis for external engagement and facilitating the development of tools by global, regional, or local offices.

CRA examine and laid out the state of play and identified key threats across three priority topics: incentives OMPs, biosimilars of OMPs, and external reference pricing. Based on the research, we developed first drafts of a potential company positions, drawing on other industry positions. We then validated initial positions through internal stakeholder interviews resulting in pressure-tested and revised positions.

CRA enabled our client to reach internal alignment on gap analysis, including likelihood of a threat materializing and its impact on the company. We identified additional topics that the company should prioritize for policy advocacy and defined needs for proof points or evidence to support key messages.